Related Experiment Videos
Algorithms for neuroleptic-associated tardive movement disorders.
1Department of Neuropsychiatry, Okayama University Medical School, Japan. kazufuak@cc.okayama-u.ac.jp
Psychiatry and Clinical Neurosciences
|November 24, 1999
Summary
Prolonged neuroleptic use can cause tardive movement disorders, impacting quality of life. Management involves adjusting neuroleptic regimens and specific treatments like anticholinergics or clonidine for different movement disorders.
Area of Science:
- Neuroscience
- Pharmacology
- Movement Disorders
Background:
- Prolonged neuroleptic exposure is a significant risk factor for tardive movement disorders.
- These movement disorders negatively impact patients' quality of life.
- Identifying specific risk factors for individual tardive movement disorders is crucial.
Purpose of the Study:
- To outline management strategies for tardive movement disorders.
- To discuss the modification of neuroleptic regimens.
- To present treatment algorithms for specific tardive movement disorders.
Main Methods:
- Review of risk factors associated with prolonged neuroleptic use.
- Modification of neuroleptic regimens, prioritizing lower-potency antipsychotics.
- Exploration of pharmacological interventions for specific tardive syndromes.
Main Results:
- Management requires careful adjustment of neuroleptic medication.
- High-dose anticholinergics or dantrolene sodium may help tardive dystonia.
- Reduced anticholinergic dosage or clonidine can be effective for tardive dyskinesia and tardive akathisia.
Conclusions:
- Tardive movement disorders necessitate individualized treatment approaches.
- Neuroleptic regimen modification is a cornerstone of management.
- Specific pharmacotherapies offer targeted relief for distinct tardive syndromes.